I agree that this site is using cookies. You can find further informations here.
X
Elferink, Marloes A. G.
359  results:
Online X
Search for persons X
?
1

520P Guidelines for time-to-event endpoints in gastrointest..:

Vissers, P. ; Elferink, M.A.G. ; Bonsing, B....
Annals of Oncology.  35 (2024)  - p. S207 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Corrigendum to "Trends in incidence, treatment, and relativ..:

Swartjes, Hidde ; Sijtsma, Femke P.C. ; Elferink, Marloes A.G....
European Journal of Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Trends in incidence, treatment, and relative survival of co..:

Swartjes, Hidde ; Sijtsma, Femke P.C. ; Elferink, Marloes A.G....
European Journal of Cancer.  205 (2024)  - p. 114104 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Adjuvant chemotherapy in patients with clinically node-nega..:

Kwakman, Johannes J.M. ; Bond, Marinde J.G. ; Demichelis, Ramzi M....
European Journal of Cancer.  197 (2024)  - p. 113466 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Impact of colorectal cancer screening on survival after met..:

Hamers, Patricia A.H. ; Vink, Geraldine R. ; Elferink, Marloes A.G....
European Journal of Cancer.  196 (2024)  - p. 113429 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Trends and Variation in the Use of Radiotherapy in Non-meta..:

Verrijssen, A.E. ; Evers, J. ; van der Sangen, M....
Clinical Oncology.  36 (2024)  4 - p. 221-232 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Cumulative Incidence, Risk Factors, and Overall Survival of..:

Boute, Tara C. ; Swartjes, Hidde ; Greuter, Marjolein J.E....
Cancer Research Communications.  4 (2024)  2 - p. 607-616 , 2024
Link: https://doi.org/10.1158/..
 
?
8

71P Real-world treatment patterns in patients with metastat..:

Elferink, M.A.G. ; van Erning, F.N. ; Sijtsma, F.P.C....
Annals of Oncology.  35 (2024)  - p. S34-S35 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Do efficacy results obtained from randomized controlled tri..:

Verweij, Stefan ; Ahmed, Wouter ; Zhou, Guiling...
Pharmacoepidemiology and Drug Safety.  33 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
10

Differences in patient- and tumor characteristics, treatmen..:

Galanos, Laskarina ; Rijken, Anouk ; Elferink, Marloes...
European Journal of Surgical Oncology.  50 (2024)  2 - p. 107362 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Supplementary Figure 1 from Cumulative Incidence, Risk Fact..:

Tara C. Boute ; Hidde Swartjes ; Marjolein J.E. Greuter...
doi:10.1158/2767-9764.25315085.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
12

Supplementary Table 5 from Cumulative Incidence, Risk Facto..:

Tara C. Boute ; Hidde Swartjes ; Marjolein J.E. Greuter...
doi:10.1158/2767-9764.25315070.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
13

Supplementary Text 1 from Cumulative Incidence, Risk Factor..:

Tara C. Boute ; Hidde Swartjes ; Marjolein J.E. Greuter...
doi:10.1158/2767-9764.25315064.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
14

Supplementary Table 3 from Cumulative Incidence, Risk Facto..:

Tara C. Boute ; Hidde Swartjes ; Marjolein J.E. Greuter...
doi:10.1158/2767-9764.25315076.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
15

Supplementary Table 2 from Cumulative Incidence, Risk Facto..:

Tara C. Boute ; Hidde Swartjes ; Marjolein J.E. Greuter...
doi:10.1158/2767-9764.25315079.v1.  , 2024
Link: https://doi.org/10.1158/..
 
1-15